Johannes Oldenburg

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 54

Top Topics

Sickle Cell Disease

Venous Thromboembolism

Top Venues

Haemophilia : the official journal of the World Federation of Hemophilia

International journal of molecular sciences

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Fabian Tomschi, Jamil Hmida, Steffen Herzig, Pia Ransmann, Marius Brühl, Alexander Schmidt, Marie Herzig, Georg Goldmann, Andreas Christian Strauß, Johannes Oldenburg, Heinrich Richter, Thomas Hilberg
Physical activity and factor VIII levels in patients with haemophilia: A real-world prospective observational study. Haemophilia : the official journal of the World Federation of Hemophilia (2024)
Barbara Preisler, Behnaz Pezeshkpoor, Anja Merzenich, Sandra Ohlenforst, Heiko Rühl, Vytautas Ivaškevičius, Ute Scholz, Hagen Bönigk, Wolfgang Eberl, Barbara Zieger, Anna Pavlova, Johannes Oldenburg
Genetic Landscape of Factor VII Deficiency: Insights from a Comprehensive Analysis of Pathogenic Variants and Their Impact on Coagulation Activity. International journal of molecular sciences 25 (4) (2024)
Cihan Ay, Mariasanta Napolitano, Abel Hassoun, Radovan Tomic, Cedric Martin, Wilfried Seifert, Karen Pinachyan, Johannes Oldenburg
Classification of recombinant factor VIII products and implications for clinical practice: A systematic literature review. Haemophilia : the official journal of the World Federation of Hemophilia 30 (3) (2024)
Pia Ransmann, Marius Brühl, Jamil Hmida, Georg Goldmann, Johannes Oldenburg, Anna Christina Strauss, Thorsten Hagedorn, Frank Alexander Schildberg, Thomas Hilberg, Andreas Christian Strauß
Determination of body composition by dual x-ray absorptiometry in persons with haemophilia. Haemophilia : the official journal of the World Federation of Hemophilia (2024)
Fabian Tomschi, Jamil Hmida, Steffen Herzig, Pia Ransmann, Marius Brühl, Alexander Schmidt, Marie Herzig, Georg Goldmann, Andreas Christian Strauß, Johannes Oldenburg, Heinrich Richter, Thomas Hilberg
Physical activity and factor VIII levels in patients with haemophilia: A real-world prospective observational study. Haemophilia : the official journal of the World Federation of Hemophilia 30 (2) (2024)
Steven W Pipe, Peter Collins, Christophe Dhalluin, Gili Kenet, Christophe Schmitt, Muriel Buri, Victor Jimenez Yuste, Flora Peyvandi, Guy Aaron Young, Johannes Oldenburg, Maria Elisa Mancuso, Kaan Kavakli, Anna Kiialainen, Sonia Deb, Markus Niggli, Tiffany Chang, Michaela Lehle, Karin C J Fijnvandraat
Emicizumab prophylaxis in infants with hemophilia A (HAVEN 7): primary analysis of a phase 3b open-label trial. Blood 143 (14) (2024)
Barbara Preisler, Behnaz Pezeshkpoor, Anja Merzenich, Sandra Ohlenforst, Heiko Rühl, Vytautas Ivaškevičius, Ute Scholz, Hagen Bönigk, Wolfgang Eberl, Barbara Zieger, Anna Pavlova, Johannes Oldenburg
Genetic Landscape of Factor VII Deficiency: Insights from a Comprehensive Analysis of Pathogenic Variants and Their Impact on Coagulation Activity. International journal of molecular sciences 25 (4) (2024)
Anna Christina Strauss, Natascha Marquardt, Johannes Oldenburg, Claus Christian Pieper, Ulrike Attenberger, Jamil Hmida, Charlotte Rommelspacher, Sebastian Koob, Andreas Christian Strauß
Self-conducted sonographic monitoring of the knee in patients with haemophilia-A feasibility study. Haemophilia : the official journal of the World Federation of Hemophilia 30 (4) (2024)
Steven W Pipe, Peter Collins, Christophe Dhalluin, Gili Kenet, Christophe Schmitt, Muriel Buri, Victor Jimenez Yuste, Flora Peyvandi, Guy Aaron Young, Johannes Oldenburg, Maria Elisa Mancuso, Kaan Kavakli, Anna Kiialainen, Sonia Deb, Markus Niggli, Tiffany Chang, Michaela Lehle, Karin C J Fijnvandraat
Emicizumab prophylaxis in infants with hemophilia A (HAVEN 7): primary analysis of a phase 3b open-label trial. Blood 143 (14) (2024)
Cihan Ay, Mariasanta Napolitano, Abel Hassoun, Radovan Tomic, Cedric Martin, Wilfried Seifert, Karen Pinachyan, Johannes Oldenburg
Classification of recombinant factor VIII products and implications for clinical practice: A systematic literature review. Haemophilia : the official journal of the World Federation of Hemophilia (2024)
Cihan Ay, Mariasanta Napolitano, Abel Hassoun, Radovan Tomic, Cedric Martin, Wilfried Seifert, Karen Pinachyan, Johannes Oldenburg
Classification of recombinant factor VIII products and implications for clinical practice: A systematic literature review. Haemophilia : the official journal of the World Federation of Hemophilia 30 (3) (2024)
Barbara Preisler, Behnaz Pezeshkpoor, Anja Merzenich, Sandra Ohlenforst, Heiko Rühl, Vytautas Ivaškevičius, Ute Scholz, Hagen Bönigk, Wolfgang Eberl, Barbara Zieger, Anna Pavlova, Johannes Oldenburg
Genetic Landscape of Factor VII Deficiency: Insights from a Comprehensive Analysis of Pathogenic Variants and Their Impact on Coagulation Activity. International journal of molecular sciences 25 (4) (2024)
Steven W Pipe, Peter Collins, Christophe Dhalluin, Gili Kenet, Christophe Schmitt, Muriel Buri, Victor Jimenez Yuste, Flora Peyvandi, Guy Aaron Young, Johannes Oldenburg, Maria Elisa Mancuso, Kaan Kavakli, Anna Kiialainen, Sonia Deb, Markus Niggli, Tiffany Chang, Michaela Lehle, Karin C J Fijnvandraat
Emicizumab prophylaxis in infants with hemophilia A (HAVEN 7): primary analysis of a phase 3b open-label trial. Blood 143 (14) (2024)
Pål André Holme, Jan Blatný, Takashi Nakano, Riitta Lassila, Niamh O'Connell, Cédric Hermans, Maria Teresa Alvarez-Roman, Claude G Negrier, Antonio Coppola, Johannes Oldenburg
Moving towards Normalization of haemostasis and health equity: Evolving treatment goals for haemophilia A. Haemophilia : the official journal of the World Federation of Hemophilia (2024)
Fabian Tomschi, Jamil Hmida, Steffen Herzig, Pia Ransmann, Marius Brühl, Alexander Schmidt, Marie Herzig, Georg Goldmann, Andreas Christian Strauß, Johannes Oldenburg, Heinrich Richter, Thomas Hilberg
Physical activity and factor VIII levels in patients with haemophilia: A real-world prospective observational study. Haemophilia : the official journal of the World Federation of Hemophilia 30 (2) (2024)
Barbara Preisler, Behnaz Pezeshkpoor, Anja Merzenich, Sandra Ohlenforst, Heiko Rühl, Vytautas Ivaškevičius, Ute Scholz, Hagen Bönigk, Wolfgang Eberl, Barbara Zieger, Anna Pavlova, Johannes Oldenburg
Genetic Landscape of Factor VII Deficiency: Insights from a Comprehensive Analysis of Pathogenic Variants and Their Impact on Coagulation Activity. International journal of molecular sciences 25 (4) (2024)
Anna Christina Strauss, Natascha Marquardt, Johannes Oldenburg, Claus Christian Pieper, Ulrike Attenberger, Jamil Hmida, Charlotte Rommelspacher, Sebastian Koob, Andreas Christian Strauß
Self-conducted sonographic monitoring of the knee in patients with haemophilia-A feasibility study. Haemophilia : the official journal of the World Federation of Hemophilia (2024)
Jens Müller, Thilo Albert, Claudia Klein, Silvia Horneff, Heiko Rühl, Bernd Pötzsch, Georg Goldmann, Natascha Marquardt, Johannes Oldenburg
Comprehensive laboratory assessment of lonoctocog alfa versus octocog alfa in severe haemophilia A. Haemophilia : the official journal of the World Federation of Hemophilia (2024)
Mohammad S Akhter, Hassan A Hamali, Hina Rashid, Gasim Dobie, Aymen M Madkhali, Abdullah A Mobarki, Johannes Oldenburg, Arijit Biswas
Mitochondria: Emerging Consequential in Sickle Cell Disease. Journal of clinical medicine 12 (3) (2023)
Steven W Pipe, Peter W Collins, Christophe Dhalluin, Gili Kenet, Christophe Schmitt, Muriel Buri, Victor Jimenez Yuste, Flora Peyvandi, Guy Aaron Young, Johannes Oldenburg, Maria Elisa Mancuso, Kaan Kavakli, Anna Kiialainen, Sonia Deb, Markus Niggli, Tiffany Chang, Michaela Lehle, Karin C J Fijnvandraat
Emicizumab prophylaxis in infants with hemophilia A (HAVEN 7): primary analysis of a phase 3b, open-label trial. Blood (2023)
Jens Müller, Sonja Neimanis, Jörg Kahle, Thilo Albert, Stephan Schultze Strasser, Bonita Rup, Bernd Pötzsch, Christoph Königs, Johannes Oldenburg, null null
Two-center validation of assays for the detection of binding and neutralizing anti-factor VIII antibodies. Haemophilia : the official journal of the World Federation of Hemophilia (2023)
Mohammad S Akhter, Hassan A Hamali, Hina Rashid, Gasim Dobie, Aymen M Madkhali, Abdullah A Mobarki, Johannes Oldenburg, Arijit Biswas
Mitochondria: Emerging Consequential in Sickle Cell Disease. Journal of clinical medicine 12 (3) (2023)
Steven W Pipe, Peter W Collins, Christophe Dhalluin, Gili Kenet, Christophe Schmitt, Muriel Buri, Victor Jimenez Yuste, Flora Peyvandi, Guy Aaron Young, Johannes Oldenburg, Maria Elisa Mancuso, Kaan Kavakli, Anna Kiialainen, Sonia Deb, Markus Niggli, Tiffany Chang, Michaela Lehle, Karin C J Fijnvandraat
Emicizumab prophylaxis in infants with hemophilia A (HAVEN 7): primary analysis of a phase 3b, open-label trial. Blood (2023)
Johannes Oldenburg, Gary Benson, Takashi Nakano, Susan Halimeh, Tadashi Matsushita, Anne Nørland, Mohd Nawi Wahid, Laszlo Nemes
Cases of less-than-expected FVIII activity in previously treated patients during post-marketing surveillance of N8-GP. Haemophilia : the official journal of the World Federation of Hemophilia (2023)
Mohammad S Akhter, Hassan A Hamali, Hina Rashid, Gasim Dobie, Aymen M Madkhali, Abdullah A Mobarki, Johannes Oldenburg, Arijit Biswas
Mitochondria: Emerging Consequential in Sickle Cell Disease. Journal of clinical medicine 12 (3) (2023)
Jamil Hmida, Thomas Hilberg, Pia Ransmann, Fabian Tomschi, Claudia Klein, Sebastian Koob, Alexander Franz, Heinrich Richter, Johannes Oldenburg, Andreas Christian Strauß
Most subjectively affected joints in patients with haemophilia - what has changed after 20 years in Germany? Haemophilia : the official journal of the World Federation of Hemophilia 28 (4) (2022)
Hamideh Yadegari, Muhammad Ahmer Jamil, Natascha Marquardt, Johannes Oldenburg
A Homozygous Deep Intronic Variant Causes Von Willebrand Factor Deficiency and Lack of Endothelial-Specific Secretory Organelles, Weibel-Palade Bodies. International journal of molecular sciences 23 (6) (2022)
Suvoshree Ghosh, Johannes Oldenburg, Katrin J Czogalla-Nitsche
The Role of GRP and MGP in the Development of Non-Hemorrhagic VKCFD1 Phenotypes. International journal of molecular sciences 23 (2) (2022)
Wolfgang A Miesbach, Hermann Eichler, Katharina Holstein, Susanne Holzhauer, Robert Klamroth, Ralf Knöfler, Christoph Male, Martin Olivieri, Johannes Oldenburg, Andreas Tiede
Electronic diaries in the management of haemophilia gene therapy: Perspective of an expert group from the German, Austrian and Swiss Society on Thrombosis and Haemostasis (GTH). Haemophilia : the official journal of the World Federation of Hemophilia 28 (2) (2022)
Sara Reda, Eva Rudde, Jens Müller, Nasim Shahidi Hamedani, Johannes Oldenburg, Bernd Pötzsch, Heiko Rühl
Variation in Plasma Levels of Apixaban and Rivaroxaban in Clinical Routine Treatment of Venous Thromboembolism. Life (Basel, Switzerland) 12 (5) (2022)
Muhammad Ahmer Jamil, Sneha Singh, Osman El-Maarri, Johannes Oldenburg, Arijit Biswas
Exploring Diverse Coagulation Factor XIII Subunit Expression Datasets: A Bioinformatic Analysis. International journal of molecular sciences 23 (9) (2022)
Miguel A Escobar, Maria Elisa Mancuso, Cedric Hermans, Cindy Leissinger, Wilfried Seifert, Yanyan Li, William McKeand, Johannes Oldenburg
IDELVION: A Comprehensive Review of Clinical Trial and Real-World Data. Journal of clinical medicine 11 (4) (2022)
Claudia Bernecker, Eva Maria Matzhold, Dagmar Kolb, Afrim Avdili, Lisa Rohrhofer, Annika Lampl, Martin Trötzmüller, Heike Singer, Johannes Oldenburg, Peter Schlenke, Isabel Dorn
Membrane Properties of Human Induced Pluripotent Stem Cell-Derived Cultured Red Blood Cells. Cells 11 (16) (2022)
Sara Reda, Jens Müller, Anna Pavlova, Behnaz Pezeshkpoor, Johannes Oldenburg, Bernd Pötzsch, Heiko Rühl
Functional Characterization of Antithrombin Mutations by Monitoring of Thrombin Inhibition Kinetics. International journal of molecular sciences 22 (4) (2021)
Johannes Oldenburg, Huyen Tran, Flora Peyvandi, Ramiro Núñez, Peter Trask, Sammy Chebon, Johnny N Mahlangu, Michaela Lehle, Victor Jimenez Yuste, Sylvia von Mackensen
Health-related quality of life and health status in adolescent and adult people with haemophilia A without factor VIII inhibitors-A non-interventional study. Haemophilia : the official journal of the World Federation of Hemophilia 27 (3) (2021)
Haider Mussawy, Michael Kehrer, André Strahl, Tim Rolvien, Jan Hubert, Frank Timo Beil, Dieter Christian Wirtz, Johannes Oldenburg, Katharina Holstein, Andreas Christian Strauß
Clinical and patient reported outcome in total ankle replacement compared to ankle fusion in end-stage haemophilic arthropathy. Haemophilia : the official journal of the World Federation of Hemophilia 27 (6) (2021)
Barbara Preisler, Behnaz Pezeshkpoor, Atanas Banchev, Ronald Fischer, Barbara Zieger, Ute Scholz, Heiko Rühl, Bettina Kemkes-Matthes, Ursula Schmitt, Redlich Antje, Sule Unal, Hans-Jürgen Laws, Martin Olivieri, Johannes Oldenburg, Anna Pavlova
Familial Multiple Coagulation Factor Deficiencies (FMCFDs) in a Large Cohort of Patients-A Single-Center Experience in Genetic Diagnosis. Journal of clinical medicine 10 (2) (2021)
Nasim Shahidi Hamedani, Arijit Biswas, Oliver Rudan, Rosa Tönges, Carlotta Meyring, Fabian Tolle, Günter Mayer, Johannes Oldenburg, Jens Müller, Bernd Pötzsch
Functional and Structural Characterization of Nucleic Acid Ligands That Bind to Activated Coagulation Factor XIII. Journal of clinical medicine 10 (4) (2021)
Mark W Skinner, Claude G Negrier, Ido Paz-Priel, Sammy Chebon, Victor Jimenez Yuste, Michael U Callaghan, Michaela Lehle, Markus Niggli, Johnny N Mahlangu, Amy D Shapiro, Midori Shima, Avrita Campinha-Bacote, Gallia G Levy, Johannes Oldenburg, Sylvia von Mackensen, Steven W Pipe
The effect of emicizumab prophylaxis on long-term, self-reported physical health in persons with haemophilia A without factor VIII inhibitors in the HAVEN 3 and HAVEN 4 studies. Haemophilia : the official journal of the World Federation of Hemophilia 27 (5) (2021)
Gili Kenet, Yeu-Chin Chen, Gillian Lowe, Charles Percy, Huyen Tran, Annette von Drygalski, Marc Trossaërt, Mark Reding, Johannes Oldenburg, Maria-Eva Mingot-Castellano, Young-Shil Park, Flora Peyvandi, Margareth C Ozelo, Johnny Mahlangu, Jennifer Quinn, Mei Huang, Divya B Reddy, Benjamin Kim
Real-World Rates of Bleeding, Factor VIII Use, and Quality of Life in Individuals with Severe Haemophilia A Receiving Prophylaxis in a Prospective, Noninterventional Study. Journal of clinical medicine 10 (24) (2021)
Holger Seidel, Hans-Jörg Hertfelder, Johannes Oldenburg, Johannes P Kruppenbacher, Lawrence B Afrin, Gerhard J Molderings
Effects of Primary Mast Cell Disease on Hemostasis and Erythropoiesis. International journal of molecular sciences 22 (16) (2021)
Ingo G H Schmidt-Wolf, Jens Müller, Karin Schuetze, Verena Rolfes, Rosi Bissinger, Nathalia Rosero, Ashar Ahmad, Bernardo Simoes Franklin, Berndt Zur, Holger Fröhlich, Florian Lang, Johannes Oldenburg, Bernd Pötzsch, Karin U Loeffler
Comprehensive Profiling of Blood Coagulation and Fibrinolysis Marker Reveals Elevated Plasmin-Antiplasmin Complexes in Parkinson's Disease. Biology 10 (8) (2021)
Mohammad Suhail Akhter, Hassan A Hamali, Abdullah A Mobarki, Hina Rashid, Johannes Oldenburg, Arijit Biswas
SARS-CoV-2 Infection: Modulator of Pulmonary Embolism Paradigm. Journal of clinical medicine 10 (5) (2021)
Osman El-Maarri, Muhammad Ahmer Jamil, Maria Köster, Nicole Nüsgen, Johannes Oldenburg, Markus Montag, Hans van der Ven, Katrin van der Ven
Stratifying Cumulus Cell Samples Based on Molecular Profiling to Help Resolve Biomarker Discrepancies and to Predict Oocyte Developmental Competence. International journal of molecular sciences 22 (12) (2021)
Maria Elisa Mancuso, Johannes Oldenburg, Lisa Boggio, Gili Kenet, Anthony Chan, Carmen Altisent, Wilfried Seifert, Elena Santagostino
High adherence to prophylaxis regimens in haemophilia B patients receiving rIX-FP: Evidence from clinical trials and real-world practice. Haemophilia : the official journal of the World Federation of Hemophilia 26 (4) (2020)
Carmen Escuriola-Ettingshausen, Günter Auerswald, Christoph Königs, Karin Kurnik, Ute Scholz, Robert Klamroth, Johannes Oldenburg
Optimizing the management of patients with haemophilia A and inhibitors in the era of emicizumab: Recommendations from a German expert panel. Haemophilia : the official journal of the World Federation of Hemophilia 27 (3) (2020)
Maria Elisa Mancuso, Johnny N Mahlangu, Robert Sidonio, Peter Trask, Marianne Uguen, Tiffany Chang, Midori Shima, Guy Aaron Young, Johannes Oldenburg, Sylvia von Mackensen
Health-related quality of life and caregiver burden of emicizumab in children with haemophilia A and factor VIII inhibitors-Results from the HAVEN 2 study. Haemophilia : the official journal of the World Federation of Hemophilia 26 (6) (2020)
Charles R M Hay, Midori Shima, Michael P Makris, Victor Jiménez-Yuste, Johannes Oldenburg, Kathelijn Fischer, Alfonso Iorio, Mark W Skinner, Elena Santagostino, Sylvia von Mackensen, Craig M Kessler
Challenges and key lessons from the design and implementation of an international haemophilia registry supported by a pharmaceutical company. Haemophilia : the official journal of the World Federation of Hemophilia 26 (6) (2020)
Stefan Schlabe, Kathrin Van Bremen, Georg Goldmann, Johannes Oldenburg, Anna-Maria Eis-Hübinger, Heike Zeitler, Ulrich Spengler
Acute Hepatitis E Virus infection in a hemophilic patient with acquired inhibitor during immune tolerance therapy according to modified Bonn-Malmö protocol. Haemophilia : the official journal of the World Federation of Hemophilia 25 (2) (2019)
Stefan Tiefenbacher, Manuela Albisetti, Peter Baker, Guenther Kappert, Steve Kitchen, Johanna A Kremer Hovinga, Claire Pouplard, Ute Scholz, Catherine Ternisien, Carin Borgvall, Tiago Vicente, Larisa Belyanskaya, Olaf Walter, Johannes Oldenburg, null null
Estimation of Nuwiq® (simoctocog alfa) activity using one-stage and chromogenic assays-Results from an international comparative field study. Haemophilia : the official journal of the World Federation of Hemophilia 25 (4) (2019)
Sneha Singh, Mohammad Suhail Akhter, Johannes Dodt, Amit Sharma, Senthilvelrajan Kaniyappan, Hamideh Yadegari, Vytautas Ivaskevicius, Johannes Oldenburg, Arijit Biswas
Disruption of Structural Disulfides of Coagulation FXIII-B Subunit; Functional Implications for a Rare Bleeding Disorder. International journal of molecular sciences 20 (8) (2019)
Johnny N Mahlangu, Johannes Oldenburg, Michael U Callaghan, Midori Shima, Maria Elisa Mancuso, Peter Trask, Michael Recht, Claudia Garcia, Renchi Yang, Michaela Lehle, Harrison Macharia, Elina Asikanius, Gallia G Levy, Rebecca Kruse-Jarres, Sylvia von Mackensen
Health-related quality of life and health status in persons with haemophilia A with inhibitors: A prospective, multicentre, non-interventional study (NIS). Haemophilia : the official journal of the World Federation of Hemophilia 25 (3) (2019)
Shariq Ahmed, Hamideh Yadegari, Arshi Naz, Arijit Biswas, Ulrich Budde, Nazish Saqlain, Samina Amanat, Shehla Tariq, Fazle Raziq, Shahtaj Masood, Anna Pavlova, Tahir Sultan Shamsi, Johannes Oldenburg
Characterization of the mutation spectrum in a Pakistani cohort of type 3 von Willebrand disease. Haemophilia : the official journal of the World Federation of Hemophilia 25 (6) (2019)
Johannes Oldenburg, Johnny N Mahlangu, Willem Bujan, Peter Trask, Michael U Callaghan, Guy Aaron Young, Elina Asikanius, Flora Peyvandi, Elena Santagostino, Rebecca Kruse-Jarres, Claude Negrier, Craig Kessler, Jin Xu, Jerzy Windyga, Midori Shima, Sylvia von Mackensen
The effect of emicizumab prophylaxis on health-related outcomes in persons with haemophilia A with inhibitors: HAVEN 1 Study. Haemophilia : the official journal of the World Federation of Hemophilia 25 (1) (2018)